title: Dimerization of midkine by tissue transglutaminase and its functional implication.
abstract: Midkine (MK), a retinoic acid-inducible growth/differentiation factor, serves as a substrate for tissue transglutaminase (Kojima, S. , Muramatsu, H., Amanuma, H., and Muramatsu, T. 1995. J. Biol. Chem. 270, 9590-9596). Upon incubation with transglutaminase MK forms multimers through cross-linkages. Here, we report the following results. 1) Heparin potentiated the multimer formation by MK. 2) The N- and C-terminal half domains each formed a dimer through the action of transglutaminase. 3) Gln42 or Gln44 in the N-terminal half and Gln95 in the C-terminal half served as amine acceptors in the cross-linking reaction, as judged from the incorporation of putrescine into whole MK or each half domain, and the competitive inhibition of the cross-linking by MK-derived peptides containing Gln residue(s). The strongest inhibition was obtained with Ala41-Pro51. 4) This peptide abolished the biological activity of MK to enhance the plasminogen activator activity in bovine aortic endothelial cells. The inhibition was limited against the MK monomer, and not seen against the MK dimer, separated by gel filtration chromatography. These results suggest that dimer formation through transglutaminase-mediated cross-linking is an important step as to the biological activity of MK.
authors.affiliation: Laboratory of Gene Technology and Safety, Tsukuba Life Science Center, The Institute of Physical and Chemical Research (RIKEN), Koyadai, Tsukuba, Ibaraki 305, Japan. kojima@rtc.riken.go.jp
authors.forename: S
authors.initials: S
authors.lastname: Kojima
authors.forename: T
authors.initials: T
authors.lastname: Inui
authors.forename: H
authors.initials: H
authors.lastname: Muramatsu
authors.forename: Y
authors.initials: Y
authors.lastname: Suzuki
authors.forename: K
authors.initials: K
authors.lastname: Kadomatsu
authors.forename: M
authors.initials: M
authors.lastname: Yoshizawa
authors.forename: S
authors.initials: S
authors.lastname: Hirose
authors.forename: T
authors.initials: T
authors.lastname: Kimura
authors.forename: S
authors.initials: S
authors.lastname: Sakakibara
authors.forename: T
authors.initials: T
authors.lastname: Muramatsu
mesh_terms: D000818:Animals; D000906:Antibodies; D002352:Carrier Proteins / Q000378:metabolism*; D002417:Cattle; D016207:Cytokines / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000378:metabolism; D005973:Glutamine; D006493:Heparin / Q000378:metabolism; D006801:Humans; D000078792:Midkine; D011487:Protein Conformation; D011700:Putrescine / Q000378:metabolism; D011817:Rabbits; D011503:Transglutaminases / Q000378:metabolism*
chemical_list: D000906:Antibodies; D002352:Carrier Proteins; D016207:Cytokines; D005973:Glutamine; D000078792:Midkine; D006493:Heparin; D011503:Transglutaminases; D011700:Putrescine